tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
RESEARCH TOOLSreports

Gain Therapeutics (GANX) Stock News & Sentiment

432 Followers
Reiterating Buy on Gain Therapeutics: Promising GT-02287 Parkinson’s Data and Diversified GCase Pipeline Support $8 Target
Premium
Ratings
Reiterating Buy on Gain Therapeutics: Promising GT-02287 Parkinson’s Data and Diversified GCase Pipeline Support $8 Target
11d ago
GANX
Gain Therapeutics Reports Promising GT-02287 Parkinson’s Data
Premium
Company Announcements
Gain Therapeutics Reports Promising GT-02287 Parkinson’s Data
23d ago
8K
GANX
Gain Therapeutics, Inc. (GANX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Gain Therapeutics, Inc. (GANX) Q4 Earnings Cheat Sheet
24d ago
GANX
Buy Rating on Gain Therapeutics Driven by Validated Mechanism, Compelling Phase 1b Parkinson’s Data, and Attractive Risk‑Reward Despite Near‑Term Financing Needs
Premium
Ratings
Buy Rating on Gain Therapeutics Driven by Validated Mechanism, Compelling Phase 1b Parkinson’s Data, and Attractive Risk‑Reward Despite Near‑Term Financing Needs
3M ago
GANX
Maintaining Buy on Gain Therapeutics: Strong GCase Biology, Validated GluSph Biomarker, and Favorable Risk-Reward for GT-02287 in Parkinson’s Disease
Premium
Ratings
Maintaining Buy on Gain Therapeutics: Strong GCase Biology, Validated GluSph Biomarker, and Favorable Risk-Reward for GT-02287 in Parkinson’s Disease
3M ago
GANX
Gain Therapeutics: Attractive Upside on GT-02287 Parkinson’s Data and Upcoming KOL Catalyst Supports Buy Rating
Premium
Ratings
Gain Therapeutics: Attractive Upside on GT-02287 Parkinson’s Data and Upcoming KOL Catalyst Supports Buy Rating
3M ago
GANX
Clinical and Mechanistic De-Risking of GT-02287 Underpins Buy Rating on Gain Therapeutics (GANX)
Premium
Ratings
Clinical and Mechanistic De-Risking of GT-02287 Underpins Buy Rating on Gain Therapeutics (GANX)
4M ago
GANX
More GANX News >

GANX News on the Web

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)
TipRanks News
Bullish
Reiterating Buy on Gain Therapeutics: Promising GT-02287 Parkinson’s Data and Diversified GCase Pipeline Support $8 Target
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Gain Therapeutics (GANX), CG Oncology, Inc. (CGON)
TipRanks News
Bullish
Gain Therapeutics reports Q4 EPS (61c), consensus (14c)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX)
TipRanks News
Bullish
Gain Therapeutics Reports Promising GT-02287 Parkinson’s Data
TipRanks News
Neutral
Gain announces presentations on Phase 1b clinical study of GT-02287
TipRanks News
Bullish
Gain Therapeutics, Inc. (GANX) Q4 Earnings Cheat Sheet
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GANX’s Media Buzz Sentiment?
Currently, no data Available
What is GANX’s weekly average amount of articles?
Currently, no data Available
What is GANX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NBIXNeurocrine
STAAStaar Surgical
AORTArtivion
OWLTOwlet
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week